GAS6 and neoplasm: Gas6 has displayed mitogenic activity in cell lines; however, in our cohort, Gas6 was associated with favourable prognostic markers including smaller tumour size (P=0.02), decreased levels of lymph node metastases (P=0.0002) and lower nuclear morphology (P=0.03).